Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.
Aboudaram A, Chaltiel L, Pouessel D, Graff-Cailleaud P, Benziane-Ouaritini N, Sargos P, Schick U, Créhange G, Cohen-Jonathan Moyal E, Chevreau C, Khalifa J. Aboudaram A, et al. Cancers (Basel). 2023 Feb 11;15(4):1161. doi: 10.3390/cancers15041161. Cancers (Basel). 2023. PMID: 36831503 Free PMC article.
Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.
Massabeau C, Rouquette I, Lauwers-Cances V, Mazières J, Bachaud JM, Armand JP, Delisle MB, Favre G, Toulas C, Cohen-Jonathan-Moyal E. Massabeau C, et al. Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):696-702. doi: 10.1016/j.ijrobp.2008.11.050. Epub 2009 Apr 20. Int J Radiat Oncol Biol Phys. 2009. PMID: 19386436
αv integrin: a new gastrin target in human pancreatic cancer cells.
Cayrol C, Bertrand C, Kowalski-Chauvel A, Daulhac L, Cohen-Jonathan-Moyal E, Ferrand A, Seva C. Cayrol C, et al. World J Gastroenterol. 2011 Oct 28;17(40):4488-95. doi: 10.3748/wjg.v17.i40.4488. World J Gastroenterol. 2011. PMID: 22110279 Free PMC article.
αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma.
Ducassou A, Uro-Coste E, Verrelle P, Filleron T, Benouaich-Amiel A, Lubrano V, Sol JC, Delisle MB, Favre G, Ken S, Laprie A, De Porre P, Toulas C, Poublanc M, Cohen-Jonathan Moyal E. Ducassou A, et al. Eur J Cancer. 2013 Jun;49(9):2161-9. doi: 10.1016/j.ejca.2013.02.033. Epub 2013 Apr 6. Eur J Cancer. 2013. PMID: 23566417 Clinical Trial.
Progastrin a new pro-angiogenic factor in colorectal cancer.
Najib S, Kowalski-Chauvel A, Do C, Roche S, Cohen-Jonathan-Moyal E, Seva C. Najib S, et al. Oncogene. 2015 Jun 11;34(24):3120-30. doi: 10.1038/onc.2014.255. Epub 2014 Aug 11. Oncogene. 2015. PMID: 25109333
Targeting progastrin enhances radiosensitization of colorectal cancer cells.
Kowalski-Chauvel A, Gouaze-Andersson V, Vignolle-Vidoni A, Delmas C, Toulas C, Cohen-Jonathan-Moyal E, Seva C. Kowalski-Chauvel A, et al. Oncotarget. 2017 Apr 20;8(35):58587-58600. doi: 10.18632/oncotarget.17274. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938581 Free PMC article.
69 results